VA-REGULA
25.7.2024 08:01:30 CEST | Business Wire | Press release
Regula, a global developer of forensic devices and identity verification solutions, prepared a dedicated package of expert articles focused on document verification, tailored to meet the needs of carriers, border verification authorities, the hospitality industry, and businesses during the 2024 Olympics. These resources aim to address the unique challenges posed by the influx of international visitors, ensuring seamless and secure experiences for all.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240724663488/en/
Effective Identity Verification for the Olympics 2024: how is it done? Regula's vision (Graphic: Regula)
France anticipates a significant boost in tourism and economic activity during the 2024 Olympics, with over 10 million visitors projected to generate an estimated €3 billion in revenue. This massive surge in visitors will not only increase the risk of fraud targeting consumers and businesses but also pose substantial challenges for security and access management. The influx of international guests underscores the critical need for advanced and comprehensive Identity Verification (IDV) systems.
Properly verifying and authorizing everyone at every stage of their Olympic journey is essential for maintaining security and ensuring smooth access to event venues and services.
1. Addressing Carrier Requirements for Advance Passenger Information
With recent EU regulations mandating the collection of advance passenger information, carriers face unprecedented challenges. Our topic, "How Carriers Can Tackle New Requirements for Gathering Advance Passenger Information," provides comprehensive insights and practical solutions to help carriers comply with these regulations efficiently. As the Olympics are hosted in France, this information is crucial for ensuring smooth travel experiences for millions of visitors.
2. Professional Border Verification Techniques
Border control is a critical component of international events. Our resources include:
- "How to Verify a Passport Like a Pro": A detailed guide on the best practices for passport verification.
- "How Regula Creates the Most Full and Detailed Document Reference System": An in-depth look at how Regula's advanced technology supports border control authorities with the most comprehensive document reference systems available. It contains templates of passports, ID cards, visas, banknotes, coins, driver’s licenses, and vehicle documents from all over the world.
- To gain a better understanding of the verification tools needed, from border controls to customer authorization by businesses, check the article “Regula ID Document Templates Database vs. Information Reference System”.
These topics are designed to empower border officials with the knowledge and tools needed to maintain security while facilitating the flow of visitors.
3. Transforming Travel & Hospitality with Data Entry Automation
In the hospitality sector, efficient check-ins are vital for a positive guest experience. At the same time, manual entry of ID details in hotels can often cause long lines, messes, and delays.
Our topic, "How Data Entry Automation Transforms Travel & Hospitality," highlights the latest innovations in reader technology and software. It provides examples of automated check-in processes and calls to action for hospitality businesses to leverage these advancements for a competitive edge.
4. Solving Business Challenges of Foreign Documents Verification
Businesses are facing an increase in the number of international customers, and the smart ones start adapting to the challenges of verifying foreign documents. Our article, "Foreign ID Document Verification for Businesses,” offers practical advice and solutions for businesses to navigate these complexities, ensuring they can confidently verify the identities of international customers.
To get access to all the expert articles in one place, visit the landing page “Securing the Olympics 2024”.
About Regula
Regula is a global developer of forensic devices and identity verification solutions. With our 30+ years of experience in forensic research and the largest library of document templates in the world, we create breakthrough technologies in document and biometric verification. Our hardware and software solutions allow over 1,000 organizations and 80 border control authorities globally to provide top-notch client service without compromising safety, security, or speed. Regula has been repeatedly named a Representative Vendor in the Gartner® Market Guide for Identity Verification.
Learn more at www.regulaforensics.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240724663488/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
